J+D Forecasting

In early 2024, J+D Forecasting and Evaluate united to address both local and global pharmaceutical forecasting challenges. J+D Forecasting brings industry-leading frameworks that support critical investment decisions at the country, brand, and portfolio levels. By integrating these capabilities with Evaluate’s decades of expertise in industry revenue analysis, consensus forecasting, and competitive intelligence, we are redefining how life sciences companies approach forecasting. This powerful combination - Evaluate’s world-class consensus forecasting and strategic consulting, coupled with J+D Forecasting’s bespoke forecasting models, advanced, cloud-based modelling and analytical solutions - enables our clients to generate more intelligent, consistent insights. By fostering effective collaboration across their organizations, businesses can gain a deeper understanding of their competitive landscape, uncover key opportunities, and make well-informed, timely decisions. About Evaluate Since 1996, Evaluate, a Norstella company, has empowered the life sciences industry with data-driven insights that support confident decision-making on high-value investments in treatments and markets. Our proprietary and industry data seamlessly integrate into client workflows, tools, and processes, enhancing efficiency and effectiveness. Learn more at www.evaluate.com and follow us on LinkedIn.